Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis by Priyabrata Mukherjee et al.
Mukherjee et al. Journal of Nanobiotechnology 2013, 11:23
http://www.jnanobiotechnology.com/content/11/1/23CORRECTION Open AccessCorrection: potential therapeutic application of
gold nanoparticles in B-chronic lymphocytic
leukemia (BCLL): enhancing apoptosis
Priyabrata Mukherjee1,4*, Resham Bhattacharya1, Nancy Bone2, Yean K Lee2, Chitta Ranjan Patra1,5,
Shanfeng Wang3,4,6, Lichun Lu3,4, Charla Secreto2, Pataki C Banerjee1,7, Michael J Yaszemski3,4, Neil E Kay2
and Debabrata Mukhopadhyay1,4Correction
After the publication of this work [1], it was brought to
our attention that there might have been an error during
compilation of the gel bands in Figure 1. We regret such
unintentional errors and any inconvenience this may
have caused. In order to ensure that the published figure
is correct, we have repeated the experiments to provide
a corrected version of Figure 1.* Correspondence: mukherjee.priyabrata@mayo.edu
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Figure 1 Immunoblot analysis of CLL B cells exposed to gold
particles (Au) alone, AbVF alone at 5 and 25 μg/ml and AU-
AbVF at 5 and 25 μg/ml. Note the prominent PARP cleavage,
decrease in caspase 3, Mcl-1 and moderate change in Bcl-2 for CLL
B cells treated with Au-AbVF at 25 μg/ml. These changes were
noted but less evident for Au-AbVF at the 5 μg/ml dose.
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